Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
- Nona Biosciences has announced a licensing agreement with the University of Alabama at Birmingham to support research in B cell development.
- UAB, represented by Dr. James Kobie, will use Nona's H2L2 Harbour Mice® platform for developing fully human antibodies.
- Dr. Jingsong Wang, Chairman of Nona Biosciences, expressed excitement about supporting UAB's research efforts.
- The research aims to address questions about the human B cell receptor repertoire for developing therapeutic antibodies for infectious diseases and oncology.
Insights by Ground AI
Does this summary seem wrong?
47 Articles
47 Articles
All
Left
3
Center
8
Right
2
Coverage Details
Total News Sources47
Leaning Left3Leaning Right2Center8Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 23%
C 62%
15%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage